ORGS - Orgenesis Inc
IEX Last Trade
0.6723
-0.016 -2.306%
Share volume: 84,483
Last Updated: Fri 30 Aug 2024 08:38:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.69
-0.02
-2.25%
Summary score
33%
Profitability
25%
Dept financing
15%
Liquidity
60%
Performance
39%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-38.46%
Return on assets
-8.28%
Return on sales
-206.36%
Return on invested capital
19.9%
Total debt ratio
65.53%
Debt ratio change over timeo
-6.07%
Current Ratio
1.11%
Quick Ratio
1.05%
Cash Position Ratio
0.9%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-77.89%
Return on assets
-14.89%
Return on sales
-802.71%
Return on invested capital
269.61%
Total debt ratio
60.03%
Debt ratio change over timeo
-4.45%
Current Ratio
3.05%
Quick Ratio
3.01%
Cash Position Ratio
2.67%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-30.87%
Return on assets
-22.46%
Return on sales
-1530.76%
Return on invested capital
558.8%
Total debt ratio
25.98%
Debt ratio change over time
-2.33%
Current Ratio
5.28%
Quick Ratio
5.27%
Cash Position Ratio
4.96%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
172.6%
Return on assets
-34.07%
Return on sales
1326.05%
Return on invested capital
-157.05%
Total debt ratio
-607.42%
Debt ratio change over time
-6.07%
Current Ratio
-8.33%
Quick Ratio
-7.85%
Cash Position Ratio
-6.27%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ORGS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -38.46% | -3.05% | 11.55% | 6.27% |
| Return on assets | -8.28% | 3.6% | 3.57% | 5.27% |
| Return on sales | -206.36% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 19.9% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 43% | 77% | 75% |
| Total debt ratio | 65.53% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -6.07% | 6.09% | 6.03% | 1.53% |
| Dept financing | 16% | 50% | 43% | 14% |
| Current Ratio | 3.05% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 3.01% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.67% | 1.48% | 0.76% | 1.49% |
| Liquididy | 33% | 35% | 61% | 73% |
| Short-term ratios | ORGS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -77.89% | -25.62% | 17.94% | 7.14% |
| Return on assets | -14.89% | 3.26% | 3.67% | 4.71% |
| Return on sales | -802.71% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 269.61% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 60.03% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -4.45% | -23.44% | 9.66% | 0.6% |
| Dept financing | 14% | 25% | 45% | 8% |
| Current Ratio | 3.05% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 3.01% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.67% | 1.48% | 0.76% | 1.49% |
| Liquididy | 72% | 45% | 36% | 63% |